Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis

Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced results of a pre-clinical study demonstrating Ampion inhibits an important pro-inflammatory pathway in the types of immune cells... Read More

Friday April 9, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, lupus nephritis, Dr. David Bar-Or

CU: Carbon dioxide levels reflect COVID-19 risk

CU: Carbon dioxide levels reflect COVID-19 risk

BOULDER -- Tracking carbon dioxide levels indoors is an inexpensive and powerful way to monitor the risk of people getting COVID-19, according to new research from the Cooperative Institute for... Read More

Friday April 9, 2021 0 comments Tags: Boulder, CU Boulder, COVID-19, Zhe Peng

Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress

Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress

ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) revealed preliminary positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in... Read More

Wednesday March 17, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Inhaled Ampion, COVID-19, Michael Macaluso

Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending

Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending

DENVER -- Everside Health (formerly Paladina Health, Activate Healthcare and Healthstat), announced it has been approved to administer the COVID-19 vaccine in 22 states. With pending approval in... Read More

Monday March 1, 2021 0 comments Tags: Denver, Everside Health, COVID-19, Chris Miller

Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater

Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater

LOVELAND -- Hach , a leader in water analysis, and Canada-based LuminUltra , a leader in biological diagnostic testing, have partnered to offer the world's first rapid, on-site testing solution for... Read More

Friday February 26, 2021 0 comments Tags: Loveland, Hach, LuminUltra, James Harbridge, Pat Whalen, COVID-19

CSU vaccine research advances to develop coronavirus vaccine for next pandemic

CSU vaccine research advances to develop coronavirus vaccine for next pandemic

FORT COLLINS -- As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other... Read More

Wednesday February 24, 2021 0 comments Tags: Fort Collins, CSU, SolaVAX, Ray Goodrich, COVID-19

Ampio adds new hospitals in trial for inhalation treatment of COVID-19

Ampio adds new hospitals in trial for inhalation treatment of COVID-19

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced the addition of two new study sites to further the expansion of its ongoing U.S. Phase I clinical trial for inhalation... Read More

Wednesday February 24, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Mike Macaluso, COVID-19

Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19

Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19

FORT COLLINS -- Cytocom, Inc. today provided an update regarding its CYTO-200 portfolio of clinical programs. Cytocom said it has submitted an Investigational New Drug (IND) application with... Read More

Tuesday February 16, 2021 0 comments Tags: Fort Collins, Cytocom, COVID-19, CYTO-205, Michael Handley